Suppliers and packagers for MICONAZOLE 3

MICONAZOLE 3

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Sun Pharma Canada	MICONAZOLE 3	miconazole nitrate	CREAM;VAGINAL	076773	ANDA	TARGET Corporation	11673-391-06	1 TUBE, WITH APPLICATOR in 1 CARTON (11673-391-06) / 25 g in 1 TUBE, WITH APPLICATOR	2005-03-02
Sun Pharma Canada	MICONAZOLE 3	miconazole nitrate	CREAM;VAGINAL	076773	ANDA	Genomma Lab USA, Inc.	50066-070-01	1 TUBE, WITH APPLICATOR in 1 CARTON (50066-070-01) / 25 g in 1 TUBE, WITH APPLICATOR	2005-03-02
Sun Pharma Canada	MICONAZOLE 3	miconazole nitrate	CREAM;VAGINAL	076773	ANDA	Genomma Lab USA, Inc.	50066-070-03	1 TUBE, WITH APPLICATOR in 1 CARTON (50066-070-03) / 25 g in 1 TUBE, WITH APPLICATOR	2005-03-02
Sun Pharma Canada	MICONAZOLE 3	miconazole nitrate	CREAM;VAGINAL	076773	ANDA	Sun Pharmaceutical Industries, Inc.	51672-2070-9	1 TUBE, WITH APPLICATOR in 1 CARTON (51672-2070-9) / 25 g in 1 TUBE, WITH APPLICATOR	2005-03-02

Suppliers and packagers for MICONAZOLE 3

Last updated: June 18, 2026

Miconazole 3 (Miconazole 3) Suppliers: Who Makes It, Supplies It, and Competes in the Supply Chain

Miconazole 3 is a branded and generic-used label name for antifungal therapy that typically appears as miconazole nitrate in vaginal formulations (cream/gel/suppositories or applicator products) and, in some markets, as topical miconazole formats. The supplier universe is therefore split by dosage form (vaginal vs topical), strength, and pack type (with or without applicator).

Actionable supply-chain takeaways:

• Supplier coverage depends on whether “MICONAZOLE 3” is referenced as a vaginal antifungal regimen (most common search intent) or a topical miconazole product.
• For tendering, purchasing, or competitive mapping, the most reliable supplier list comes from product-level labeling and distribution listings (not the active ingredient alone).
• The downstream competitive set typically includes European generic manufacturers, local packers, and distribution partners, with API supply frequently sourced from specialized chemical/API producers.

Which companies supply MICONAZOLE 3 to pharmacies and distributors?

Featured snippet answer: Suppliers vary by market and dosage form. The same “MICONAZOLE 3” label can point to different miconazole nitrate presentations (not interchangeable across applicators/pack sizes). To build a defensible supplier roster, buyers map by the exact finished dose described on-pack.

Common finished-dose supplier archetypes

1. Finished-dose manufacturers of miconazole nitrate vaginal preparations (cream/gel/suppositories) that sell under generic or local brand packaging.
2. Packers and distributors that repackage bulk into local “3-day” or “3” regimen packs.
3. Brand owners in specific geographies where “MICONAZOLE 3” is an established trade name.

How to structure a supplier shortlist

• Lock the product definition by dosage form (vaginal cream, vaginal gel, vaginal suppositories).
• Lock the strength and pack regimen (commonly “3” day regimens in consumer markets).
• Lock the packaging format (with applicators vs without).
• Lock the country listing (EU vs UK vs US vs LATAM changes the supplier set materially).

What API suppliers provide miconazole nitrate to finished-dose manufacturers?

Featured snippet answer: Miconazole nitrate API is generally supplied by specialty chemical manufacturers that also provide downstream antifungal intermediates and related azole antifungal APIs.

Typical API supply chain for miconazole

• API producers produce miconazole nitrate under cGMP and regulatory documentation.
• Finished-dose manufacturers formulate into vaginal or topical vehicles (bases, solvents, emulsions, or suppository matrices depending on dosage form).
• Contract manufacturers and packers handle local conversion into specific “3” pack formats.

API-to-finished linkage used in procurement

• Buyers often qualify API sources through DMFs/CEP dossiers and vendor qualification audits.
• For competitive analysis, the finished-dose supplier is more visible than API suppliers unless the API supplier is publicly tied via filings or public manufacturing disclosures.

Which suppliers make miconazole nitrate vaginal products marketed as “3-day” regimens?

Featured snippet answer: The highest concentration of “MICONAZOLE 3”-type products is in vaginal antifungal regimens, where manufacturers supply finished-dose packs that align to a 3-day course in multiple countries.

Dosage-form splits that affect supplier lists

• Vaginal cream products: suppliers tied to emulsions and applicator compatibility.
• Vaginal gel products: suppliers tied to carbomer/gel matrices and release profiles.
• Vaginal suppositories/pessaries: suppliers tied to lipophilic bases and consistent melting profiles.

How does MICONAZOLE 3 compare across countries in terms of suppliers and pack formats?

Featured snippet answer: Supplier sets differ by regulatory market because product availability and pack formats follow local authorization pathways and tendering norms.

Market-by-market patterns

• EU/EEA: multiple generics with common packaging archetypes; local wholesalers play a large role.
• UK: fewer branded placements, higher weight on generic products and national distributors.
• US: miconazole vaginal antifungal products exist, but “Miconazole 3” naming may not map 1:1 to US tradenames; sourcing is often through distributor chains and wholesaler listings.

What distributors commonly supply MICONAZOLE 3 to clinics, pharmacies, and wholesalers?

Featured snippet answer: Distributors typically supply by national wholesaler networks and regional pharma distribution agreements. The “supplier” buyers see on invoices is often a wholesaler rather than a manufacturing site.

How to identify true supply sources

• Distinguish between:
  • Manufacturer (site of manufacture for the finished dose)
  • Marketing authorization holder (brand owner on pack)
  • Distributor/wholesaler (invoice entity)
• For procurement and compliance, qualification should track manufacturer and quality systems tied to the product, not only the invoice distributor.

What generic suppliers compete for MICONAZOLE 3 tenders and hospital formularies?

Featured snippet answer: Competition is driven by tender price, pack size, and supply reliability rather than API uniqueness, since miconazole is widely generically supplied.

Procurement drivers that determine which suppliers win

• Product definition match (dosage form, applicator system, pack regimen)
• Lead time and continuity of supply
• Local regulatory dossier readiness
• Contract manufacturing capacity and lot-release stability

What manufacturing/IP barriers affect entry for new suppliers of MICONAZOLE 3?

Featured snippet answer: For miconazole-based products, barriers are typically regulatory and operational (QMS, dossier filing, and formulation/vehicle controls) rather than strong active-ingredient exclusivity.

Barriers that still matter

• Formulation reproducibility (vehicle and applicator fit)
• Stability testing by product type
• Sterility/bioburden controls (especially for vaginal applicator products)
• Regulatory dossier strategy (DMF/CEP alignment and national variations)

What is the most reliable way to build a supplier list for MICONAZOLE 3 for buying or licensing?

Featured snippet answer: Build the supplier list at the level of the finished product that matches the on-pack definition, then map:

• manufacturer site(s),
• MAH/brand or authorization holder,
• distributor/wholesaler chain,
• pack size and regimen.

Procurement-ready vendor mapping template

• Finished product name exactly as on pack
• Dosage form
• Strength
• Pack count and regimen
• MAH/authorization holder
• Manufacturing site(s)
• Distributor/wholesaler invoice entity
• Country of authorization/listing
• Lead time and typical minimum order quantity (when available from procurement systems)

Key Takeaways

• “MICONAZOLE 3” supplier identification depends on the exact dosage form and pack regimen tied to local labeling.
• The supplier universe is best mapped at the finished product level (manufacturer and MAH) and then connected to distributors for ordering.
• For competitive procurement, classify by vaginal cream/gel vs suppositories, lock strength and applicator format, and then populate the supplier list from product-specific listings and tender documents.

FAQs

1) Is MICONAZOLE 3 the same as miconazole nitrate vaginal cream?

Not always. “MICONAZOLE 3” labeling can vary by country in dosage form and pack format, even when the active is miconazole nitrate.

2) Do the same suppliers provide both topical miconazole and vaginal “MICONAZOLE 3”?

Often no. Topical and vaginal products use different formulation systems and packaging controls, so supplier capabilities can diverge.

3) How can a buyer confirm the manufacturer behind MICONAZOLE 3 on invoices?

Check the labeled manufacturer/MAH and the packaging artwork, then map that to the manufacturing site on regulatory product listings.

4) Which supplier set is most competitive: branded or generic “MICONAZOLE 3”?

In most markets, competitive pressure comes from generic manufacturers and local packers tied to procurement and reimbursement cycles.

5) What affects delivery reliability for MICONAZOLE 3 products?

Manufacturing lot release, packaging lead times (especially applicators), and national distributor network constraints.

---

References

No sources were cited because the request did not provide a specific country, dosage form, strength, or product identifier, and no product-level supplier list can be generated without those facts.